| Literature DB >> 32473390 |
Mani Divya1, Sekar Vijayakumar2, Jingdi Chen3, Baskaralingam Vaseeharan4, Esteban F Durán-Lara5.
Abstract
SARS-CoV-2 is a causative agent of Coronavirus disease-19 (COVID-19), which is considered as a fatal disease for public health apprehension worldwide. This pathogenic virus can present everywhere. As it is a virus it can extend easily and cause severe illness to humans. Hence, an efficient international attentiveness of plan is necessary to cure and prevent. In this review, epidemic outbreak, clinical findings, prevention recommendations of COVID-19 and suggestive medicinal value of south Indian plant sources have been discussed. Though the varieties of improved approaches have been taken in scientific and medicinal concern, we have to pay attention to the medicinal value of the plant-based sources to prevent these types of pandemic diseases. This is one of the suggestive and effective ways to control the spreading of viruses. In the future, it is required to provide medicinal plant-based clinical products (Masks, sanitizers, soap, etc.,) with better techniques by clinicians to contend the scarcity and expose towards the nature-based medicine rather than chemical drugs. This may be a benchmark for the economical clinical trials of specific plant material to treat the viral diseases in the future.Entities:
Keywords: COVID-19; Pandemic; Prevention; South indian medicinal plants
Mesh:
Year: 2020 PMID: 32473390 PMCID: PMC7253980 DOI: 10.1016/j.micpath.2020.104277
Source DB: PubMed Journal: Microb Pathog ISSN: 0882-4010 Impact factor: 3.738
Fig. 1Model structure of the nCoV.
At the time of preparing this manuscript as on 25th May 2020 a tabular data accurate with the following information of affected people with COVID-19.
| S. No | Country | Affected | Death | Recovered |
|---|---|---|---|---|
| 1. | United states | 1,689,618 | 99,381 | 451,745 |
| 2. | Spain | 282,852 | 28,752 | 196,958 |
| 3. | Italy | 229,858 | 32,785 | 140,479 |
| 4. | France | 182,584 | 28,367 | 64,617 |
| 5. | India | 141,228 | 4057 | 58,727 |
| 6. | Iran | 137,724 | 7451 | 107,713 |
| 7. | China | 82,985 | 4634 | 78,268 |
| 8. | Singapore | 31,960 | 23 | 14,876 |
| 9. | Southkorea | 11,206 | 267 | 10,226 |
| 10. | Thailand | 3042 | 57 | 2928 |
Fig. 2Illustrative representation of the nCoV symptoms.
Fig. 3Preventive measures to stop spreading nCoV.
List of south Indian medicinal plants inhibits several types of viruses.
| Indian Medicinal plants (South) | Virus | Effectiveness | Reference |
|---|---|---|---|
| Dengue virus | Leaf extract (Aqueous) inhibits DEN-2 | Parida et al., 2002 [ | |
| Dengue virus | Leaf extract has significant anti-dengue activity | Monika et al., 2008 [ | |
| Dengue virus | NVK provides protection against DENV and CHIKV | Jain et al., 2019 [ | |
| Human adenovirus (type 1) | Inhibits human ADV-1 in dose dependant manner | Yamai et al., 2003 [ | |
| Human rhino virus (HRV) & Respiratory syncytial virus (RSV) | Bark extract endowed with antivirus activity against HRV & RSV | Cagno et al., 2015 [ | |
| Herpes simplex virus | Extract possess strong antiviral against HSV | Arthanari et al., 2012 [ | |
| Herpes simplex virus | Exhibits anti HSV-1&2 | Tolo et al., 2006 [ | |
| Herpes simplex virus | Inhibits earlier stages of HSV multiplications | Mukerjee et al., 2013 [ | |
| Polio virus | Extracts inhibits polio replications | DeFelipe et al., 2006 [ | |
| Human herpes virus-3 | Phytochemical extract exhibits potential anti viral activity | Angamuthu et al., 2019 [ | |
| Human immuno deficiency virus | Inhibits HIV replication | Notka et al., 2004 [ | |
| Hepatitis B virus | Plant extract had lost HBV antigen surface | Thyagarajan et al., 1988 [ | |
| Hepatitis B virus | Inhibits HBV antigen | Beula et al., 2012 [ | |
| HIV-1 | Plant extract against HIV-1 | Jayasundar et al., 2019 [ | |
| HIV | Leaf extract control HIV infections | Chinnaiyan et al., 2013 [ | |
| HIV | Leaves used to inhibit viral replication | Eze et al., 2014 [ | |
| Epstein bar virus (EBV) | Leaves and seeds inhibits activity against EBV activation | Murakami et al., 1998 [ |